Publication: 2773

Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients with Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572
      QxMD      Google Scholar   
Citation:
Cancer vol 124 (7) 1455-1463
Year:
2018
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
7
Parents:
70   71   501   575   953  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
Pfizer, Bayer  
Grants:
U10CA0225224, U10CA180821, U10CA180882, UG1CA189863  
Corr. Author:
 
Authors:
                               
Networks:
LAPS-MN026, MCRC, METROMIN, MI005, MN017, VA009   
Study
NCCTG-N0572
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1/2
Keywords: